However, this certainly does not apply to the pharmaceutical industry, as Sandra Phlippen discovered. Physical proximity between organisations plays a much smaller role than expected when it comes to gaining access to valuable external knowledge about new medicines.
On Wednesday 5 November 2008, Phlippen will be defending her dissertation Come close and co create. Proximities in pharmaceutical innovation networks, at Erasmus University Rotterdam, the Netherlands.
For her dissertation, Sandra Phlippen examined how different forms of proximity between organisations affect their capacity for strategic collaboration, which in recent years has become increasingly important in the pharmaceutical industry. Previously new medicines were mostly brought out by the laboratories of the large pharmaceutical companies, but their long period of hegemony is well and truly over. The lack of successful internal medicines, the expiry of patent rights from past successes, and finally the enormous expansion of alternative technology for the development of medicines have prompted pharmaceutical companies to explore opportunities for working together with external partners. As a result, innovations in the biopharmaceutical industry generally occur through partnerships between biotech companies, universities and pharmaceutical companies.
Phlippen made a distinction in her research between the effect of co-location (geographical proximity), the effect of being embedded in a network (relational proximity) and the effect of being in a common knowledge field (cognitive proximity). She discovered that the effect of geographical clustering is very limited, in spite of the many billions that are being invested in setting up business parks for companies and universities. “It is much more important for organisations to be ‘embedded’ in (often international) networks based on previous strategic partnerships. New partnership links for developing medicines are primarily the result of both organisations having a common partner with whom they have worked in the past. What matters, therefore, is not where you are, but whom you know,” explains Sandra Phlippen.
Once a collaborative partnership between two organisations has been established, it is important that there is sufficient common, that is, overlapping. knowledge between them. At the same time, the number of external partnerships cannot be too great, because knowledge about new medicines is so complex that the transfer of knowledge between two organisations requires the same researchers to work on both external and internal projects. It is only under this condition that knowledge that has been acquired externally can be successfully applied internally.
Yvette Nelen | alfa
Microtechnology industry is hiring – positive developments of past years continue
09.04.2018 | IVAM Fachverband für Mikrotechnik
RWI/ISL-Container Throughput Index with minor decline on a high overall level
20.03.2018 | RWI – Leibniz-Institut für Wirtschaftsforschung
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.
Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
19.04.2018 | Materials Sciences
19.04.2018 | Physics and Astronomy
19.04.2018 | Physics and Astronomy